MedTrace Logo

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

NCT01576198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2227

Last updated 2016-07-14

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood, tissue, or bone marrow from patients with cancer in the laboratory may help doctors to learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in samples from younger patients with Wilms tumor.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

nucleic acid amplification

OTHER

diagnostic laboratory biomarker analysis

OTHER

medical chart review

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Elizabeth J. Perlman, MD · Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility

Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01576198 on ClinicalTrials.gov